Skip to Main Content

Paper Details

Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
J Clin Endocrinol Metab
36
2020
ACC, ACC2, Adrenocortical Cancer, Anti-PD1, CD8, CD8+, CU, CU-ACC2, CU-ACC2-M2B patient-derived xenograft, CU-ACC2-humanized cord blood-BALB/c-Rag2nullIl2rnullSirpaNOD model, Granzyme B, Granzyme B+ CD8+ T cells, HLA-DR, HLA-DR+ T cells, Humanized, Mouse, PD-1, PD1, Tumor, adrenocortical carcinoma, human, human CD8+, human CD8+ T cells, humanized, malignancies, metastatic liver lesion, mice, mouse, patient, patients, pembrolizumab, tumor, tumor infiltrating lymphocyte, xenograft mouse model
Author NameAffiliation
Kimberly R JordanUniversity of Colorado School of Medicine at Colorado Anschutz Medical Campus
Wells A MessersmithUniversity of Colorado School of Medicine at Colorado Anschutz Medical Campus
Margaret E WiermanUniversity of Colorado School of Medicine at Colorado Anschutz Medical Campus
Margaret E WiermanResearch Service Veterans Affairs Medical Center
  • 1 - 4

Datasets

Release 1.2